乳酸林格氏液定制水化预防内镜逆行胰胆管造影术后胰腺炎:一项随机对照试验
这项前瞻性、多中心、双盲随机试验在3家韩国三级医院纳入首次接受ERCP的患者,1:1随机分为定制标准水化组与定制积极水化组。结果显示,定制积极水化组胰腺炎发生率为3.5%(6/172),低于定制标准水化组的9.4%(16/171),相对危险度0.37(95%CI 0.15-0.93,P=0.03),两组胰腺炎严重程度及容量超负荷相关并发症无差异。
要点
- 定制积极水化组胰腺炎发生率3.5%(6/172),低于定制标准水化组的9.4%(16/171)。
- 相对危险度0.37(95%CI 0.15-0.93,P=0.03)。
- 两组胰腺炎严重程度(P=0.80)及容量超负荷相关并发症(P=0.32)无差异。
核心结论
- 根据ERCP后4-6小时腹痛或血清淀粉酶升高情况实施定制积极水化是安全的,并可预防ERCP术后胰腺炎发生。
研究设计与样本
- 前瞻性、多中心、双盲、随机对照试验,在3家韩国三级医院开展。
- 首次接受ERCP的患者按1:1随机分配至定制标准水化组和定制积极水化组。
- 共344例患者被随机分配(定制标准水化组171例,定制积极水化组172例)。
- 主要终点为ERCP术后胰腺炎发生,采用意向性治疗分析。
主要发现
- 定制标准水化组胰腺炎发生率为9.4%(16/171),定制积极水化组为3.5%(6/172)。
- 相对危险度0.37(95%CI 0.15-0.93,P=0.03)。
- 两组胰腺炎严重程度无差异(P=0.80)。
- 两组容量超负荷相关并发症无差异(P=0.32)。
关键数值与推荐
- 定制标准水化组:ERCP术中及术后给予乳酸林格氏液1.5 mL/kg/hr。
- 定制积极水化组:ERCP术后给予20 mL/kg负荷量,术中及术后给予3 mL/kg/hr。
- 两组均在ERCP后4-6小时评估血清淀粉酶升高和疼痛;两者均无则停止水化,任一存在则按原速率继续水化至8小时。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Aggressive hydration using lactated Ringer's solution prevents postendoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP). Concerns of this strategy are large volume and lengthy hydration. Our study aimed to evaluate the efficacy of tailored aggressive hydration (TAH) for PEP prevention. METHODS: In this prospective, multicenter, double-blinded, randomized trial conducted across 3 tertiary Korean hospitals, patients who underwent ERCP for the first time were randomly assigned (1:1) to the tailored standard hydration (TSH) and TAH groups. The TSH group received 1.5 mL/kg/hr lactated Ringer's solution during and after ERCP, whereas the TAH group was administered a 20 mL/kg bolus post-ERCP and 3 mL/kg/hr during and after the procedure. Both groups were assessed for elevated serum amylase levels and pain 4-6 hours after ERCP. If both were absent, hydration was discontinued. If either was present, hydration was continued at the original rate until 8 hours. The primary end point was PEP development and was analyzed on an intention-to-treat analysis. RESULTS: A total of 344 patients were randomly assigned to treatment groups (171 to the TSH group and 172 to the TAH group). PEP was observed in 9.4% (16/171) in the TSH group and 3.5% (6/172) in the TAH group (relative risk 0.37, 95% confidence interval 0.15-0.93, P = 0.03). No difference was identified between the 2 groups in PEP severity ( P = 0.80) and complications related to volume overload ( P = 0.32). DISCUSSION: TAH according to the presence of abdominal pain or elevated serum amylase levels at 4-6 hours after ERCP is safe and prevents PEP development.
引用
- Cho E, Kim SH, Park CH, et al. Tailored Hydration With Lactated Ringer's Solution for Postendoscopic Retrograde Cholangiopancreatography Pancreatitis Prevention: A Randomized Controlled Trial. Am J Gastroenterol. 2024. PMID: 38912692. doi:10.14309/ajg.0000000000002903
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。